Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
Holding LYEL?
Track your performance easily

Lyell Immunopharma (LYEL) Similar Stocks

72 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Lyell Immunopharma
$345.60M
-1.63
-13.46%
1 Buy
2 Hold
0 Sell
Moderate Buy
Adaptimmune Therapeutics
$265.93M
-3.01
43.05%
5 Buy
2 Hold
1 Sell
Moderate Buy
Crispr Therapeutics AG
$4.22B
-15.36
4.58%
10 Buy
6 Hold
2 Sell
Moderate Buy
Fate Therapeutics
$441.85M
-2.27
65.11%
3 Buy
9 Hold
0 Sell
Hold
Intellia Therapeutics
$2.29B
-4.11
-34.48%
16 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
LYEL
Lyell Immunopharma
1.35
-0.10
-6.90%
ADAP
Adaptimmune Therapeutics
1.04
0.30
40.54%
CRSP
Crispr Therapeutics AG
49.59
3.03
6.51%
FATE
Fate Therapeutics
3.88
1.63
72.44%
NTLA
Intellia Therapeutics
22.52
-11.47
-33.75%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis